Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We investigated the prevalence of sarcopenic obesity (SO) and its relationship with metabolic syndrome in a community-based elderly cohort in Korea. RESEARCH DESIGN AND METHODS: In this study, 287 men and 278 women aged 65 or older were recruited. Sarcopenia was defined as the appendicular skeletal muscle mass (ASM) divided by height squared (Ht2) (kg/m2) or by weight (Wt) (%) of <1 SD below the sex-specific mean for young adults. Obesity was defined as a visceral fat area ≥100 cm2. RESULTS: The prevalence of SO was 16.7% in men and 5.7% in women with sarcopenia defined by ASM/Ht2; however, it was 35.1% in men and 48.1% in women by ASM/Wt. Using ASM/Wt, the homeostasis model assessment of insulin resistance of subjects with SO was higher and they were at higher risk for metabolic syndrome (odds ratio [OR] 8.28 [95% CI 4.45–15.40]) than the obese (5.51 [2.81–10.80]) or sarcopenic group (2.64 [1.08–6.44]). CONCLUSIONS: SO defined by ASM/Wt was more closely associated with metabolic syndrome than either sarcopenia or obesity alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most clinical studies have reported that sarcopenic obesity is associated with metabolic syndrome [136,137,138].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [137]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lim et al. observed a higher risk of metabolic syndrome among adults with sarcopenic obesity [defined using DXA-measured ALM/weight (%) and visceral fat area] [odds ratio (OR): 8.28, 95% CI: 4.45–15.40] than among those with obesity (OR: 5.51, 95% CI: 2.81–10.80) or sarcopenia (OR: 2.64, 95% CI: 1.08–6.44) in a cross-sectional study of 565 participants aged ≥65 years from the Korean Longitudinal”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [89]
In the citing paper
“In contrast, using the definition ALM/ht2, the ORs of metabolic syndrome were lower in the obesity group than in the sarcopenic obesity group (2.90 [95% CI: 1.28–6.57] vs. 4.80 [95% CI: 2.63–8.75]) (89).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [89]
In the citing paper
“Regarding body FM, the upper sex-specific cut-offs of 40% for females and 30% for males have been proposed as best predictors of mortality in the NHANES sample (American population) using DXA [59].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“(4) and 2) ASM as a percentage of body weight (ASM/Wt), which was modified from the study of Janssen et al.”
MethodJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692
Body Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 1×
“Second, previous studies used BMI or the percentage of fat mass for the definition of obesity to obtain a sufficient number of subjects within the group for statistical analysis (14).”
MethodSarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937 · cited 1×
“(1) showed that the prevalence of metabolic syndrome was highest in the group of nonsarcopenic obese subjects.”
BackgroundNew Criteria for `Obesity Disease' in Japan
Oda, E. (2006) · Circulation Journal · doi:10.1253/circj.70.150 · Cited by 783
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 1×
“These factors activate a vicious cycle leading to accelerated sarcopenia, additional weight gain largely in the form of fat, and ultimately to physical disability (1, 9-12).”
Background
Research works printed but not linked: 1
- World Health Organization Western Pacific Region, 2000, The Asia-Pacific perspective: redefining obesity and its treatment
Cited by
Fragala, M. S., Cadore, E. L., Dorgo, S., Izquierdo, M., Kraemer, W. J., Peterson, M. D., & Ryan, E. D. (2019) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003230 · Cited by 1,290
New trends on obesity and NAFLD in Asia
Fan, J.-G., Kim, S.-U., & Wong, V. W.-S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.003 · Cited by 1,083
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
Atkins, J. L., Whincup, P. H., Morris, R. W., Lennon, L. T., Papacosta, O., & Wannamethee, S. G. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12652 · Cited by 509
Batsis, J. A., Mackenzie, T. A., Barre, L. K., Lopez-Jimenez, F., & Bartels, S. J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.117 · Cited by 479
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
Koo, B. K., Kim, D., Joo, S. K., Kim, J. H., Chang, M. S., Kim, B. G., Lee, K. L., & Kim, W. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.019 · Cited by 440
“The skeletal muscle is the primary tissue responsible for insulin-mediated glucose disposal, and the prominent role of skeletal muscle in insulin resistance has been confirmed by epidemiological [9,10] and experimental [11] studies.”
BackgroundSelf-citationRosqvist, F., Iggman, D., Kullberg, J., Cedernaes, J., Johansson, H.-E., Larsson, A., Johansson, L., Ahlström, H., Arner, P., Dahlman, I., et al. (2014) · Diabetes · doi:10.2337/db13-1622 · Cited by 429
“Although lean tissue was a secondary outcome, this finding is intriguing since obese persons with reduced lean tissue (sarcopenic obesity) are more insulin-resistant and at higher risk for physical disability (46,47).”
BackgroundKim, K. M., Jang, H. C., & Lim, S. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.015 · Cited by 403
Self-citationMuscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
Wannamethee, S. G., & Atkins, J. L. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500169x · Cited by 404
Hong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
Hong, H. C., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2014) · Hepatology · doi:10.1002/hep.26716 · Cited by 385
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
Obesity phenotypes and their paradoxical association with cardiovascular diseases
Vecchié, A., Dallegri, F., Carbone, F., Bonaventura, A., Liberale, L., Portincasa, P., Frühbeck, G., & Montecucco, F. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.10.020 · Cited by 329
Coutinho, T., Goel, K., Corrêa de Sá, D., Carter, R. E., Hodge, D. O., Kragelund, C., Kanaya, A. M., Zeller, M., Park, J. S., Kober, L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.035 · Cited by 334
“Additionally, normal eight centrally obese subjects may have sarcopenia, a ondition linked to poor functional capacity (26) and worse etabolic profile (27).”
BackgroundSarcopenia and sarcopenic obesity
Choi, K. M. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.193 · Cited by 344
Lee, Y.-H., Jung, K. S., Kim, S. U., Yoon, H.-J., Yun, Y. J., Lee, B.-W., Kang, E. S., Han, K.-H., Lee, H. C., & Cha, B.-S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.051 · Cited by 340
Kim, Y.-S., Lee, Y., Chung, Y.-S., Lee, D.-J., Joo, N.-S., Hong, D., Song, G. E., Kim, H.-J., Choi, Y. J., & Kim, K.-M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls071 · Cited by 327
Self-citationCollins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C., Zernicke, R. F., & Hart, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00112 · Cited by 308
“This suggests important roles for both fat accumulation and muscle loss in the etiology of MetS (Lim et al., 2010).”
BackgroundDonini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326
“(2010) [72] coexistence of obesity and sarcopenia (distinct diagnosis) Sarcopenia: ASM/h(2) and ASM/Wt; Obesity: VFA Sarcopenia: ASM/h(2) < 7.”
BackgroundHealth Consequences of Sarcopenic Obesity: A Narrative Review
Roh, E., & Choi, K. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00332 · Cited by 304
“Among elderlymen in the ConcordHealth andAging Project, lowmuscle mass and sarcopenic obesity (defined based on ALM/BMI and % body fat according to FNIH criteria) were not associated with institutionalization (35).”
BackgroundInfluentialChung, J.-Y., Kang, H.-T., Lee, D.-C., Lee, H.-R., & Lee, Y.-J. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.09.007 · Cited by 283
Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults
Kim, N. H., Park, Y., Kim, N. H., & Kim, S. G. (2021) · Age and Ageing · doi:10.1093/ageing/afaa208 · Cited by 273
Self-citationTian, S., & Xu, Y. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12579 · Cited by 274
Chin, S. O., Rhee, S. Y., Chon, S., Hwang, Y.-C., Jeong, I.-K., Oh, S., Ahn, K. J., Chung, H. Y., Woo, J.-T., Kim, S.-W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060119 · Cited by 252
Self-citationLiu, C., Wong, P. Y., Chung, Y. L., Chow, S. K., Cheung, W. H., Law, S. W., Chan, J. C. N., & Wong, R. M. Y. (2023) · Obesity Reviews · doi:10.1111/obr.13534 · Cited by 247
“for WC, over 90 cm in men and 85 cm in women were most frequently used to define central obesity, whereas two studies used the definition of visceral fat over 100 cm(2).(43,46) Five studies combined the criteria including BF% or BMI to diagnose obesity.”
MethodLow muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES
Son, J. W., Lee, S. S., Kim, S. R., Yoo, S. J., Cha, B. Y., Son, H. Y., & Cho, N. H. (2017) · Diabetologia · doi:10.1007/s00125-016-4196-9 · Cited by 222
Equine Pituitary Pars Intermedia Dysfunction
McFarlane, D. (2011) · Veterinary Clinics of North America: Equine Practice · doi:10.1016/j.cveq.2010.12.007 · Cited by 217
Buch, A., Carmeli, E., Boker, L. K., Marcus, Y., Shefer, G., Kis, O., Berner, Y., & Stern, N. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.008 · Cited by 227
The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease
Kim, T. N., & Choi, K. M. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25077 · Cited by 225
“Moreover, muscle mass adjusted for weight was negatively correlated with BMI, visceral fat area, and the homostasis model assessment of insulin resistance whereas muscle mass adjusted by height squared was positively associated with these CMD risk factors [Lim et al., 2010b].”
BackgroundMethodInfluentialPolyzos, S. A., & Margioris, A. N. (2018) · Hormones · doi:10.1007/s42000-018-0049-x · Cited by 212
“tients with sarcopenic obesity than in those with sarcopenia alone or obesity alone in the Korean Longitudinal Study on Health and Aging (KLoSHA) [45].”
BackgroundKim, T. N., Park, M. S., Lim, K. I., Choi, H. Y., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Choi, H., Baik, S. H., et al. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04433.x · Cited by 208
Self-citationBatsis, J. A., Mackenzie, T. A., Lopez-Jimenez, F., & Bartels, S. J. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.09.003 · Cited by 203
“[24] Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, et al.”
BackgroundSarcopenic obesity is closely associated with metabolic syndrome
Lu, C.-W., Yang, K.-C., Chang, H.-H., Lee, L.-T., Chen, C.-Y., & Huang, K.-C. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.02.003 · Cited by 198
Kim, G., Lee, S., Lee, Y., Jun, J. E., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Hepatology · doi:10.1002/hep.30049 · Cited by 198
“(47) SMI was proposed to be more closely associated with metabolic parameters compared with the index of ASM/height2.(34) Because not only ASM—but also body weight—determines SMI, and body weight change could affect SMI or NAFLD incidence or resolution, the results may not be confined to the effect of skeletal muscle…”
BackgroundResultInfluentialSelf-citationSarcopenic obesity in ageing: cardiovascular outcomes and mortality
Atkins, J. L., & Wannamathee, S. G. (2020) · British Journal of Nutrition · doi:10.1017/s0007114520002172 · Cited by 187
Levine, M. E., & Crimmins, E. M. (2012) · Obesity · doi:10.1038/oby.2012.20 · Cited by 186
Peterson, M. D., Gordon, P. M., & Hurvitz, E. A. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01052.x · Cited by 176
“‘sarcopenic obesity’) (56,67); the confluence of which represents a robust predictor for subsequent attenuation of muscle strength and quality (56,57), and of course, cardiometabolic disease risk (68,69).”
BackgroundSarcopenia: An Independent Predictor of Mortality in Community-Dwelling Older Korean Men
Kim, J. H., Lim, S., Choi, S. H., Kim, K. M., Yoon, J. W., Kim, K. W., Lim, J.-Y., Park, K. S., Jang, H. C., & Kritchevsky, S. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu050 · Cited by 176
“We have shown previously that ASM/wt relates more closely to the cardiometabolic syndrome than does ASM/ht(2) (4,7).”
Self-citationBaek, S. J., Nam, G. E., Han, K. D., Choi, S. W., Jung, S. W., Bok, A. R., Kim, Y. H., Lee, K. S., Han, B. D., & Kim, D. H. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0011-3 · Cited by 182
Self-citationLee, S., Kim, T., & Kim, S. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37696 · Cited by 182
Physical Activity and Sarcopenic Obesity: Definition, Assessment, Prevalence and Mechanism
Lee, D.-C., Shook, R. P., Drenowatz, C., & Blair, S. N. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0028 · Cited by 177
Du, Y., Wang, X., Xie, H., Zheng, S., Wu, X., Zhu, X., Zhang, X., Xue, S., Li, H., Hong, W., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0432-x · Cited by 175
Ectopic fat and cardiometabolic and vascular risk
Lim, S., & Meigs, J. B. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.077 · Cited by 173
Self-citationSarcopenic obesity in aging population: current status and future directions for research
Kohara, K. (2014) · Endocrine · doi:10.1007/s12020-013-9992-0 · Cited by 171
Kim, M. K., Baek, K. H., Song, K.-H., Il Kang, M., Park, C. Y., Lee, W. Y., & Oh, K. W. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1602 · Cited by 171
“Sarcopenia was defined (12, 13) as an ASM divided by Wt (ASM/Wt) that was less than 2 SD below the mean of a sample of 2392 healthy adults aged 20–40 yr (1054 men, 1338 women).”
BackgroundInfluentialBatsis, J. A., Mackenzie, T. A., Jones, J. D., Lopez-Jimenez, F., & Bartels, S. J. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.03.028 · Cited by 166
Ryu, M., Jo, J., Lee, Y., Chung, Y.-S., Kim, K.-M., & Baek, W.-C. (2013) · Age and Ageing · doi:10.1093/ageing/aft063 · Cited by 168
“Using the heightadjusted (ASM/ht2) definition, the prevalence tended to be underestimated in women, with sarcopenia identified in 14.2% of men, but in only 2.4% of women (sarcopenic obesity was present in only 0.2% in each gender).”
BackgroundMethodInfluentialSelf-citationHan, K., Park, Y.-M., Kwon, H.-S., Ko, S.-H., Lee, S.-H., Yim, H. W., Lee, W.-C., Park, Y. G., Kim, M. K., & Park, Y.-M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086902 · Cited by 158
“Sarcopenia was defined [4] as an ASM/Wt ,1 SD below the mean of a sample of healthy adults aged 20 to 40 years.”
BackgroundSelf-citationAn Overview of Sarcopenic Obesity
Cauley, J. A. (2015) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2015.04.013 · Cited by 194
Sarcopenia, Frailty, and Diabetes in Older Adults
Jang, H. C. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.3.182 · Cited by 152
Self-citationKim, K., & Park, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21168-5 · Cited by 142
Self-citationMoon, S. J., Kim, T. H., Yoon, S. Y., Chung, J. H., & Hwang, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130740 · Cited by 140
Visceral adiposity is negatively associated with bone density and muscle attenuation
Zhang, P., Peterson, M. D., Su, G. L., & Wang, S. C. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.081778 · Cited by 142
Geriatrics Fact Sheet in Korea 2021
Baek, J. Y., Lee, E., Jung, H., & Jang, I. (2021) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.21.0063 · Cited by 139
Kim, T. N., Park, M. S., Ryu, J. Y., Choi, H. Y., Hong, H. C., Yoo, H. J., Kang, H. J., Song, W., Park, S. W., Baik, S. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115407 · Cited by 133
“Visceral obesity was defined as a visceral fat area exceeding 100 cm(2) in both men and women [16].”
BackgroundSarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
Fukushima, H., Yokoyama, M., Nakanishi, Y., Tobisu, K., & Koga, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115895 · Cited by 136
“Sarcopenic obesity, the coexistence of obesity and low muscle mass, is considered to be a worst-case scenario due to the combination of two health-related risk factors [26, 27].”
BackgroundKhadra, D., Itani, L., Tannir, H., Kreidieh, D., Masri, D. E., & Ghoch, M. E. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i5.311 · Cited by 130
Sarcopenic obesity in cirrhosis—The confluence of 2 prognostic titans
Eslamparast, T., Montaño‐Loza, A. J., Raman, M., & Tandon, P. (2018) · Liver International · doi:10.1111/liv.13876 · Cited by 133
Beavers, K. M., Lyles, M. F., Davis, C. C., Wang, X., Beavers, D. P., & Nicklas, B. J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004895 · Cited by 126
Kim, J.-H., Cho, J. J., & Park, Y. S. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.3.264 · Cited by 126
“In a previous study conducted in Korea, the height-adjusted definition was observed to underestimate the prevalence of sarcopenia and sarcopenic obesity (22), and the weight-adjusted definition was more closely correlated with metabolic risk factors compared to the height-adjusted definition (5).”
BackgroundInfluentialSelf-citationSarcopenia and the cardiometabolic syndrome: A narrative review
Bahat, G., & İlhan, B. (2016) · European Geriatric Medicine · doi:10.1016/j.eurger.2015.12.012 · Cited by 144
Fukuda, T., Bouchi, R., Takeuchi, T., Tsujimoto, K., Minami, I., Yoshimoto, T., & Ogawa, Y. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0700-5 · Cited by 129
“Furthermore, in a large cross-sectional analysis of 14,528 subjects from the National Health and Nutrition Examination Survey III reported that individuals with sarcopenic obesity had the highest risk of adverse glucose metabolism [12].”
BackgroundWu, I., Lin, C., Hsiung, C. A., Wang, C., Wu, C., Chan, D. D., Li, T., Lin, W., Huang, K., Chen, C., et al. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12193 · Cited by 124
Sarcopenia and fatty liver disease
Kim, J. A., & Choi, K. M. (2019) · Hepatology International · doi:10.1007/s12072-019-09996-7 · Cited by 134
Self-citationHamer, M., Batty, G. D., & Kivimaki, M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.124 · Cited by 121
Sarcopenic obesity as an independent risk factor of hypertension
Park, S. H., Park, J. H., Song, P. S., Kim, D. K., Kim, K. H., Seol, S. H., Kim, H. K., Jang, H. J., Lee, J. G., Park, H. Y., et al. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.06.002 · Cited by 118
Self-citationLucassen, E. A., de Mutsert, R., le Cessie, S., Appelman‐Dijkstra, N. M., Rosendaal, F. R., van Heemst, D., den Heijer, M., Biermasz, N. R., & for the NEO study group (2017) · PLoS ONE · doi:10.1371/journal.pone.0176685 · Cited by 128
Lee, S. W., Youm, Y., Lee, W. J., Choi, W., Chu, S. H., Park, Y.-R., & Kim, H. C. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.37 · Cited by 123
“In this study, ASM was measured by bioelectrical impedance analysis and was analyzed in three forms: ASM (kg), ASM/height2 (kg/m2), and ASM/weight (%).”
BackgroundInfluentialSelf-citationRelative Skeletal Muscle Mass Is Associated with Development of Metabolic Syndrome
Park, B. S., & Yoon, J. S. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.6.458 · Cited by 116
“According to the Korean Longitudinal Study on Health and Aging, the ratio of lower appendicular SMM to weight was more closely associated with MS than either sarcopenia or obesity alone [12].”
MethodSelf-citationSarcopenic obesity in the elderly and strategies for weight management
Li, Z., & Heber, D. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00453.x · Cited by 132
Role of hypothalamus in aging and its underlying cellular mechanisms
Kim, K., & Choe, H. K. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.04.008 · Cited by 122
Self-citationHara, N., Iwasa, M., Sugimoto, R., Mifuji‐Moroka, R., Yoshikawa, K., Terasaka, E., Hattori, A., Ishidome, M., Kobayashi, Y., Hasegawa, H., et al. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5676 · Cited by 124
“On the other hand, although it is a well-known fact that visceral obesity causes insulin resistance and leads to a high risk of developing cancer or cardiovascular events, it is also reported that sarcopenic obesity (the coexistence of sarcopenia and visceral obesity) is an advanced metabolic disorder showing severe m…”
BackgroundSarcopenia and sarcopenic obesity
Choi, K. M. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.2.86 · Cited by 113
Gortan Cappellari, G., Guillet, C., Poggiogalle, E., Ballesteros Pomar, M. D., Batsis, J. A., Boirie, Y., Breton, I., Frara, S., Genton, L., Gepner, Y., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.02.018 · Cited by 113
Sarcopenic obesity, weight loss, and mortality: the english longitudinal study of ageing
Hamer, M., & O’Donovan, G. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.152488 · Cited by 110
“metabolic, functional impairments, and mortality risk (3-9).”
Han, D.-S., Chang, K.-V., Li, C.-M., Lin, Y.-H., Kao, T.-W., Tsai, K.-S., Wang, T.-G., & Yang, W.-S. (2016) · Scientific Reports · doi:10.1038/srep19457 · Cited by 110
Associations between Sarcopenia and Metabolic Risk Factors: A Systematic Review and Meta-Analysis
Du, Y., Oh, C., & No, J. (2018) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2018.27.3.175 · Cited by 105
Armenian, S. H., Chemaitilly, W., Chen, M. Y., Chow, E. J., Duncan, C., Jones, L. W., Pulsipher, M. A., Remaley, A. T., Rovó, A., Salooja, N., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.08.019 · Cited by 111
Relationship Between Low Relative Muscle Mass and Coronary Artery Calcification in Healthy Adults
Ko, B., Chang, Y., Jung, H. S., Yun, K. E., Kim, C., Park, H. S., Chung, E. C., Shin, H., & Ryu, S. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307156 · Cited by 114
Ishii, S., Tanaka, T., Akishita, M., Ouchi, Y., Tuji, T., Iijima, K., & for the Kashiwa study investigators (2014) · PLoS ONE · doi:10.1371/journal.pone.0112718 · Cited by 112
“Several studies in older adults showed an inverse association between MetS and muscle mass [35,36], but these studies did not assess men and women separately.”
ResultSarcopenic obesity and metabolic syndrome in adult Caucasian subjects
Poggiogalle, E., Lubrano, C., Sergi, G., Coin, A., Gnessi, L., Mariani, S., Lenzi, A., & Donini, L. M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0638-1 · Cited by 106
“With respect to body composition and the metabolic profile, our findings are consistent with previous studies (11, 15, 30), showing that increased fat mass, especially visceral fat mass, and decreased muscle mass are associated with cardiometabolic abnormalities.”
InfluentialSarcopenic Obesity in Children and Adolescents: A Systematic Review
Zembura, M., & Matusik, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.914740 · Cited by 115
Kim, G., Lee, S., Jun, J. E., Lee, Y., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0659-2 · Cited by 110
“There have been various representative methods to estimate relative skeletal muscle mass, using height squared (ASM/height2), weight (ASM/body weight (Wt) = SMI), and BMI (ASM/BMI) to adjust body size [22, 26, 36], because ASM is fundamentally correlated with body size [37].”
MethodSelf-citationLow muscle mass and low muscle strength associate with nonalcoholic fatty liver disease
Gan, D., Wang, L., Jia, M., Ru, Y., Ma, Y., Zheng, W., Zhao, X., Yang, F., Wang, T., Mu, Y., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.023 · Cited by 95
Leptin in Sarcopenic Visceral Obesity: Possible Link between Adipocytes and Myocytes
Kohara, K., Ochi, M., Tabara, Y., Nagai, T., Igase, M., & Miki, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024633 · Cited by 99
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Lim, S. K., Taskinen, M., & Borén, J. (2018) · Obesity Reviews · doi:10.1111/obr.12820 · Cited by 111
“In a different context, sarcopenia, loss of muscle mass, is associated with NAFLD and diabetes.(84,85) People with sarcopenia had a twofold to threefold increased risk of NAFLD.”
BackgroundSelf-citationPrevalence Rate and Associated Factors of Sarcopenic Obesity in Korean Elderly Population
Hwang, B., Lim, J., Lee, J., Choi, N., Ahn, Y., & Park, B. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.7.748 · Cited by 107
“Previously, there were only two studies reporting the prevalence of SO in the Korean elderly population (9, 10).”
BackgroundSelf-citationPark, J., Kwon, Y., & Park, H. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.39065 · Cited by 94
Sebastiano, K. M. D., & Mourtzakis, M. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h2012-079 · Cited by 109
“These muscle losses and adipose tissue gains lead to a body composition profile termed sarcopenic obesity, which is associated with metabolic syndrome, cardiovascular disease, and type II diabetes in nonmalignant populations (Lim et al. 2010; Stephen and Janssen 2009).”
BackgroundSarcopenic obesity: An appraisal of the current status of knowledge and management in elderly people
Molino, S., Dossena, M., Buonocore, D., & Verri, M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0631-8 · Cited by 91
Kim, K. M., Lim, S. K., Oh, T. J., Moon, J. H., Choi, S. H., Lim, J., Kim, K. W., Park, K. S., & Jang, H. C. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx188 · Cited by 104
Self-citationPark, C., Yi, Y., Do, J. G., Lee, Y., & Yoon, K. J. (2018) · Medicine · doi:10.1097/md.0000000000012281 · Cited by 96
Nutrition and exercise in the management of liver cirrhosis
Toshikuni, N., Arisawa, T., & Tsutsumi, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7286 · Cited by 98
Ji, Y. S., Cheng, B., Xu, Z., Ye, H., Lu, W., Luo, X., Fu, S., & Fang, X. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.03.019 · Cited by 87
Sarcopenia Associated with Chronic Obstructive Pulmonary Disease
Kim, S. H., Shin, M., Shin, Y. B., & Kim, K. U. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.2.65 · Cited by 97
Self-citationDynapenic obesity and the risk of incident Type 2 diabetes: the english longitudinal study of ageing
Cuthbertson, D. J., Bell, J. A., Ng, S. Y., Kemp, G. J., Kivimaki, M., & Hamer, M. (2016) · Diabetic Medicine · doi:10.1111/dme.12991 · Cited by 86
Comparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk
Kim, T. N., Park, M. S., Lee, E. J., Chung, H. S., Yoo, H. J., Kang, H. J., Song, W., Baik, S. H., & Choi, K. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06831-7 · Cited by 86
Metadata
- Authors
- Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C.
- Affiliations
- Seoul National University (KR)
- Corresponding author
- Jang, Hak Chul
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-05-11
- Volume
- 33
- Issue
- 7
- Pages
- 1652-1654
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890376
- OpenAlex
- W2055418044
- Cited by
- 588
- References
- 17
- Citations by year
- 2026: 16 · 2025: 27 · 2024: 43 · 2023: 38 · 2022: 48 · 2021: 50 · 2020: 41 · 2019: 50 · 2018: 48 · 2017: 35 · 2016: 50 · 2015: 50 · 2014: 31 · 2013: 26 · 2012: 23
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- sarcopenic obesity, sarcopenia, obesity, metabolic syndrome, prevalence, older adults, appendicular skeletal muscle mass, visceral fat area, insulin resistance, sex differences
- MeSH terms
- Aged, Aged, 80 and over, Aging, Female, Humans, Insulin Resistance, Longitudinal Studies, Male, Obesity, Risk Factors, Prevalence, Logistic Models, Sex Distribution, Metabolic Syndrome, Asian People, Sarcopenia, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.